Chromogranin A (CgA), a protein released by neuroendocrine cells displaying characteristics of both nerve and hormone-producing cells, can be measured through a blood test offered by Hypro Diagnostics. This test, known as a tumor marker test, helps identify elevated CgA levels, which may signal the presence of tumors affecting the neuroendocrine system. While increased CgA levels can be associated with various health conditions, Hypro Diagnostics primarily employs CgA testing for the diagnosis and management of patients specifically dealing with neuroendocrine tumors (NETs). These tumors, found in organs like the gastrointestinal tract and lungs, can be either cancerous or non-cancerous. The comprehensive CgA test provided by Hypro Diagnostics aids in the precise assessment of neuroendocrine health.
Reviews
There are no reviews yet.